Garimella PS, Sarnak MJ. Cardiovascular disease in CKD in 2012: moving forward, slowly but surely. Nat Rev Nephrol. 2013;9(2):69–70.
Article PubMed PubMed Central Google Scholar
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (London England). 2013;382(9889):339–52.
Carney EFJNRN. The impact of chronic kidney disease on global health. 2020;16(5):251-.
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. 2016;11(7):e0158765.
Nugent RA, Fathima SF, Feigl AB, Chyung DJNCP. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. 2011;118(3):c269–77.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Preval Chronic Kidney Disease United States. 2007;298(17):2038–47.
Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14(1):13–29.
O’Neill TW, McCabe PS, McBeth J. Update on the epidemiology, risk factors and disease outcomes of osteoarthritis. Best Pract Res Clin Rheumatol. 2018;32(2):312–26.
Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Rheum Dis Clin North Am. 2008;34(3):515–29.
Article PubMed PubMed Central Google Scholar
Swain S, Coupland C, Mallen C, Kuo CF, Sarmanova A, Bierma-Zeinstra SM et al. Temporal relationship between osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary care setting. 2021;60(9):4327–39.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of Disease Study 2015. 2016;388(10053):1545–602.
Muyodi MM, Oyoo G, Bhatt K, Kayima JJEAOJ. Prevalence of and factors associated with chronic kidney disease in osteoarthritis patients at. Kenyatta Natl Hosp. 2020;14(2):72–80.
Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y, et al. Global, Regional, and National Burden of Diabetes-related chronic kidney Disease from 1990 to 2019. Front Endocrinol. 2021;12:672350.
Prieto-Alhambra D, Judge A, Javaid MK, Cooper C, Diez-Perez A, Arden NK. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 2014;73(9):1659–64.
Baker M, Perazella MA. NSAIDs in CKD: are they safe? American journal of kidney diseases. Official J Natl Kidney Foundation. 2020;76(4):546–57.
Magni A, Agostoni P, Bonezzi C, Massazza G, Menè P, Savarino V, et al. Management of Osteoarthritis: Expert Opinion on NSAIDs. Pain Therapy. 2021;10(2):783–808.
Article PubMed PubMed Central Google Scholar
Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: Core Curriculum 2019. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2019;74(1):120–31.
Liang X, Chou OHI, Cheung CL, Cheung BMY. Is hypertension associated with arthritis? The United States national health and nutrition examination survey 1999–2018. Ann Med. 2022;54(1):1767–75.
Article PubMed PubMed Central Google Scholar
Kotsis V, Martinez F, Trakatelli C, Redon J. Impact of obesity in kidney diseases. Nutrients. 2021;13(12).
Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas. 2016;89:22–8.
Hage S, Hage V, El-Khoury N, Azar H, Chelala D, Ziadé N. Musculoskeletal disorders in hemodialysis patients: different disease clustering according to age and dialysis vintage. Clin Rheumatol. 2020;39(2):533–9.
Lories RJ, Luyten FP. Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev. 2009;20(5–6):467–73.
Article CAS PubMed Google Scholar
Mobasheri A, Rayman MP, Gualillo O, Sellam J, van der Kraan P, Fearon U. The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2017;13(5):302–11.
Article CAS PubMed Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5s):S1–127.
Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023;12(12).
Mallamaci F, Pisano A, Tripepi G. Physical activity in chronic kidney disease and the EXerCise introduction to enhance trial. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association -. Eur Ren Association. 2020;35(Suppl 2):ii18–22.
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–304.
Article CAS PubMed PubMed Central Google Scholar
Xia B, Di C, Zhang J, Hu S, Jin H, Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014;95(6):495–505.
Article CAS PubMed PubMed Central Google Scholar
Li H, Li M, Liu C, He P, Dong A, Dong S, et al. Causal effects of systemic inflammatory regulators on chronic kidney diseases and renal function: a bidirectional mendelian randomization study. Front Immunol. 2023;14:1229636.
Article CAS PubMed PubMed Central Google Scholar
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J-P, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33–42.
Article CAS PubMed Google Scholar
Sohn DH, Sokolove J, Sharpe O, Erhart JC, Chandra PE, Lahey LJ, et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via toll-like receptor 4. Arthritis Res Therapy. 2012;14(1):R7.
Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, et al. Inflammation-related mechanisms in chronic kidney Disease Prediction, Progression, and Outcome. J Immunol Res. 2018;2018:2180373.
Article PubMed PubMed Central Google Scholar
He J, Cao W, Azeem I, Zhao Q, Shao Z. Transforming growth factor Beta1 being considered a novel biomarker in knee osteoarthritis. Clin Chim Acta. 2017;472:96–101.
Article CAS PubMed Google Scholar
Nakase T, Miyaji T, Tomita T, Kaneko M, Kuriyama K, Myoui A, et al. Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthr Cartil. 2003;11(4):278–84.
Shen J, Li S, Chen D. TGF-β signaling and the development of osteoarthritis. Bone Res. 2014;2:14002.
Article CAS PubMed PubMed Central Google Scholar
Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest. 1993;68(2):154–63.
Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int. 2006;70(7):1234–43.
Article CAS PubMed Google Scholar
Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 1990;346(6282):371–4.
Article CAS PubMed Google Scholar
Julovi SM, Dao A, Trinh K, O’Donohue AK, Shu C, Smith S et al. Disease-modifying interactions between chronic kidney disease and osteoarthritis: a new comorbid mouse model. RMD open. 2023;9(3).
Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–69.
Article PubMed PubMed Central Google Scholar
Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis
Comments (0)